Recent insights into the function of autophagy in cancer
R Amaravadi, AC Kimmelman, E White - Genes & development, 2016 - genesdev.cshlp.org
Macroautophagy (referred to here as autophagy) is induced by starvation to capture and
degrade intracellular proteins and organelles in lysosomes, which recycles intracellular …
degrade intracellular proteins and organelles in lysosomes, which recycles intracellular …
Mitophagy in tumorigenesis and metastasis
LP Poole, KF Macleod - Cellular and molecular life sciences, 2021 - Springer
Cells use mitophagy to remove dysfunctional or excess mitochondria, frequently in response
to imposed stresses, such as hypoxia and nutrient deprivation. Mitochondrial cargo …
to imposed stresses, such as hypoxia and nutrient deprivation. Mitochondrial cargo …
Mitophagy in cancer: a tale of adaptation
M Vara-Perez, B Felipe-Abrio, P Agostinis - Cells, 2019 - mdpi.com
In the past years, we have learnt that tumors co-evolve with their microenvironment, and that
the active interaction between cancer cells and stromal cells plays a pivotal role in cancer …
the active interaction between cancer cells and stromal cells plays a pivotal role in cancer …
Autophagy and mitophagy in cancer metabolic remodelling
Metabolic reprogramming in tumours is now recognized as a hallmark of cancer,
participating both in tumour growth and cancer progression. Cancer cells develop global …
participating both in tumour growth and cancer progression. Cancer cells develop global …
Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis
AH Chourasia, K Tracy, C Frankenberger… - EMBO …, 2015 - embopress.org
BN ip3 is a hypoxia‐inducible protein that targets mitochondria for autophagosomal
degradation. We report a novel tumor suppressor role for BN ip3 in a clinically relevant …
degradation. We report a novel tumor suppressor role for BN ip3 in a clinically relevant …
Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer
T Arumugam, V Ramachandran, KF Fournier, H Wang… - Cancer research, 2009 - AACR
A better understanding of drug resistance mechanisms is required to improve outcomes in
patients with pancreatic cancer. Here, we characterized patterns of sensitivity and resistance …
patients with pancreatic cancer. Here, we characterized patterns of sensitivity and resistance …
Sirtuins' control of autophagy and mitophagy in cancer
M Aventaggiato, E Vernucci, F Barreca… - Pharmacology & …, 2021 - Elsevier
Mammalian cells use a specialized and complex machinery for the removal of altered
proteins or dysfunctional organelles. Such machinery is part of a mechanism called …
proteins or dysfunctional organelles. Such machinery is part of a mechanism called …
Gene therapies for cancer: strategies, challenges and successes
SK Das, ME Menezes, S Bhatia… - Journal of cellular …, 2015 - Wiley Online Library
Gene therapy, which involves replacement of a defective gene with a functional, healthy
copy of that gene, is a potentially beneficial cancer treatment approach particularly over …
copy of that gene, is a potentially beneficial cancer treatment approach particularly over …
Mitophagy and cancer
AH Chourasia, ML Boland, KF Macleod - Cancer & metabolism, 2015 - Springer
Mitophagy is a selective form of macro-autophagy in which mitochondria are selectively
targeted for degradation in autophagolysosomes. Mitophagy can have the beneficial effect …
targeted for degradation in autophagolysosomes. Mitophagy can have the beneficial effect …
Phosphoinositide signalling in cancer: beyond PI3K and PTEN
TD Bunney, M Katan - Nature Reviews Cancer, 2010 - nature.com
There are numerous studies that suggest multiple links between the cellular
phosphoinositide system and cancer. As key roles in cancer have been established for PI3K …
phosphoinositide system and cancer. As key roles in cancer have been established for PI3K …